Implications of the new histological classification (WHO 2010) for pancreatic neuroendocrine neoplasms

被引：8
作者：
Crippa, S. [1 ,2 ]
Partelli, S. [1 ,2 ]
Boninsegna, L. [1 ,2 ]
Falconi, M. [1 ,2 ]
机构：
[1] Univ Verona, Dept Surg, I-37100 Verona, Italy
[2] Osped Sacro Cuore Don Calabria, Div Gen Surg, Negrar, VR, Italy
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷 / 07期
关键词：
TUMORS;
D O I：
10.1093/annonc/mds166
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1928 / 1928
页数：1
相关论文
共 50 条
[41]   New Developments in the Management of neuroendocrine Neoplasms [J].
不详 .
ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2013, 51 (02) :A2-A8
[42]   Molecular, functional, and histopathological classification of the pituitary neuroendocrine neoplasms [J].
Inomoto, Chie ;
Tahara, Shigeyuki ;
Oyama, Kenichi ;
Kimura, Midori ;
Matsuno, Akira ;
Teramoto, Akira ;
Osamura, Robert Y. .
BRAIN TUMOR PATHOLOGY, 2021, 38 (03) :183-188
[43]   Introduction to neuroendocrine neoplasms of the digestive system: definition and classification [J].
Inzani, Frediano ;
Rindi, Guido .
PATHOLOGICA, 2021, 113 (01) :1-4
[44]   Discordant risk factors between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinoma [J].
Chandra, Shruti ;
Halfdanarson, Thorvardur R. ;
Carlson, Erin E. ;
Rabe, Kari G. ;
Mahipal, Amit ;
Majumder, Shounak ;
Bamlet, William R. ;
Horibe, Masayasu ;
Tella, Sri Harsha ;
Shariq, Omair ;
Carr, Ryan M. ;
Cleary, Sean P. ;
Oberg, Ann L. ;
Antwi, Samuel O. .
ENDOCRINE-RELATED CANCER, 2025, 32 (04)
[45]   EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs) [J].
April-Monn, Simon Leonhard ;
Andreasi, Valentina ;
Schiavo Lena, Marco ;
Sadowski, Martin Carl ;
Kim-Fuchs, Corina ;
Buri, Michelle Claudine ;
Ketkar, Avanee ;
Maire, Renaud ;
Di Domenico, Annunziata ;
Schrader, Joerg ;
Muffatti, Francesca ;
Doglioni, Claudio ;
Partelli, Stefano ;
Falconi, Massimo ;
Perren, Aurel ;
Marinoni, Ilaria .
CANCERS, 2021, 13 (19)
[46]   Molecular subtyping in pancreatic neuroendocrine neoplasms: New insights into clinical, pathological unmet needs and challenges [J].
Yan, Jie ;
Yu, Shuangni ;
Jia, Congwei ;
Li, Min ;
Chen, Jie .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2020, 1874 (01)
[47]   World Health Organization grading classification for pancreatic neuroendocrine neoplasms: a comprehensive analysis from a large Chinese institution [J].
Yang, Min ;
Zeng, Lin ;
Ke, Neng-wen ;
Tan, Chun-lu ;
Tian, Bo-le ;
Liu, Xu-bao ;
Xiang, Bo ;
Zhang, Yi .
BMC CANCER, 2020, 20 (01)
[48]   Relation between WHO classification and location- and functionality-based classifications of neuroendocrine neoplasms of the digestive tract [J].
Helderman, Noah C. ;
Suerink, Manon ;
Kilinc, Gul ;
van den Berg, Jose G. ;
Nielsen, Maartje ;
Tesselaar, Margot E. T. .
NEUROENDOCRINOLOGY, 2024, 114 (02) :120-133
[49]   An update on genetically engineered mouse models of pancreatic neuroendocrine neoplasms [J].
Gaspar, Tiago Bordeira ;
Lopes, Jose Manuel ;
Soares, Paula ;
Vinagre, Joao .
ENDOCRINE-RELATED CANCER, 2022, 29 (12) :R191-R208
[50]   Impact of everolimus on Japanese patients with advanced pancreatic neuroendocrine neoplasms [J].
Lee, Lingaku ;
Ito, Tetsuhide ;
Igarashi, Hisato ;
Ueda, Keijiro ;
Fujiyama, Takashi ;
Kawabe, Ken ;
Ogawa, Yoshihiro .
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2017, 24 (02) :95-102
12345